AstraZeneca’s lung cancer drug trial shows no significant improvement
Detailed results from one of AstraZeneca’s pivotal trials of a lung cancer drug, published on Monday, showed that the experimental precision drug had no significant impact on overall survival outcomes for patients in the trial.
ENTRADAS POPULARES
Bluetongue outbreak in a Portuguese sheep farm has broken out
septiembre 19, 2024
Austria says disaster fund to rise to 1 billion euros
septiembre 19, 2024
Portugal gets help from Spain and Morocco in response to fires
septiembre 19, 2024
Drought reduces Amazon rivers to historic lows
septiembre 19, 2024
TRANSMISIÓN EN VIVO